| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 68.96B | — |
| Operating expense | — | — |
| Net income | 7.19B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, SNPHY returned +7.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +15.0% |
| 1 year | +7.8% |
| 5 years | -16.4% |
| 10 years | +0.6% |
| All-time high | $20.55 (Sep 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in SNPHY would be worth today ›No. Santen Pharmaceutical Co., Ltd. has not paid a dividend in the past 12 months.
Santen Pharmaceutical Co., Ltd. is part of the Healthcare sector.
Santen Pharmaceutical Co., Ltd. has a market cap of 3.97B USD, based on the latest quote.